GENERALI, DANIELE

GENERALI, DANIELE  

Dipartimento Universitario Clinico di Scienze mediche, chirurgiche e della salute  

Settore MED/06 - Oncologia Medica  

Docenti di ruolo di IIa fascia  

Mostra records
Risultati 1 - 20 di 236 (tempo di esecuzione: 0.024 secondi).
Titolo Data di pubblicazione Autori File
The 4th International Consensus Conference: Primary Systemic Treatment in the Management of Operable Breast Cancer: Toward the Rapid Assessment of Therapy Efficacy, 2010, Cremona, Italy 1-gen-2011 GENERALI, DANIELE +
Abemaciclib: A CDK4/6 inhibitor for the treatment of HR+/HEeR2- advanced breast cancer 1-gen-2018 Corona, Silvia PaolaGenerali, Daniele
ADAM10 mediates trastuzumab resistance and is correlated with survival in HER2 positive breast cancer 1-gen-2014 GENERALI, DANIELE +
Ado-trastuzumab emtansine (T-DM1) in HER2+ advanced breast cancer patients: does pretreatment with pertuzumab matter? 1-gen-2017 Generali, Daniele +
Advances in systemic therapy for malignant mesothelioma: Future perspectives 1-gen-2017 Sobhani, NavidCorona, Silvia PaolaBonazza, DeborahIanza, AnnaRoviello, GiandomenicoCortale, MaurizioGuglielmi, AlessandraZanconati, FabrizioGenerali, Daniele +
Advances in systemic therapy for metastatic breast cancer: future perspectives 1-gen-2017 Corona, S. P.SOBHANI, NAVIDIANZA, ANNAROVIELLO, GIANDOMENICOMUSTACCHI, GIORGIOBORTUL, MARINAZANCONATI, FABRIZIOGENERALI, DANIELE
Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trial 1-gen-2016 Generali, Daniele +
Anthracyclines strike back: Rediscovering non‐pegylated liposomal doxorubicin in current therapeutic scenarios of breast cancer 1-gen-2021 Generali D. +
Anti-Angiogenic effect of tamoxifen combined with epirubicin in breast cancer patients 1-gen-2010 GENERALI, DANIELE +
The anti-tumor efficacy of CDK4/6 inhibition is enhanced by the combination with PI3K/AKT/mTOR inhibitors through impairment of glucose metabolism in TNBC cells 1-gen-2018 Generali, Daniele +
Apatinib for the treatment of gastric cancer 1-gen-2016 ROVIELLO, GIANDOMENICOGENERALI, DANIELE +
Apatinib in metastatic gastric cancer: Can paclitaxel make the difference? 1-gen-2016 ROVIELLO, GIANDOMENICOGENERALI, DANIELE +
Apatinib: A novel receptor tyrosine kinase inhibitor for the treatment of gastric cancer 1-gen-2016 ROVIELLO, GIANDOMENICOGENERALI, DANIELE +
Are EGFR tyrosine kinase inhibitors effective in elderly patients with EGFR-mutated non-small cell lung cancer? 1-gen-2017 ROVIELLO, GIANDOMENICOGENERALI, DANIELE +
Association between ramucirumab-related hypertension and response to treatment in patients with metastatic gastric cancer 1-gen-2018 Roviello, GiandomenicoCorona, Silvia PaolaGenerali, Daniele +
Avelumab in gastric cancer 1-gen-2019 Roviello G.Generali D.De Manzini N.Sobhani N. +
Baseline Characteristics and Outcomes of Cancer Patients Infected with SARS-CoV-2 in the Lombardy Region, Italy (AIOM-L CORONA): A Multicenter, Observational, Ambispective, Cohort Study 1-gen-2021 Generali, DanieleGiudici, FabiolaBernocchi, Ottavia +
Benefit of the addition of hormone therapy to neoadjuvant anthracycline-based chemotherapy for breast cancer: comparison of predicted and observed pCR 1-gen-2018 Generali, DanieleCorona, Silvia Paola +
Bevacizumab in small cell lung cancer 1-gen-2017 Roviello, GiandomenicoSobhani, NavidGenerali, Daniele
Biological therapies for metastatic breast cancer: Antiangiogenesis 1-gen-2006 GENERALI, DANIELE +